Study Enrollment

Your details will not be published or shared.

Clinical Trial

(MASTERS-2) MultiStemŽ Administration for Stroke Treatment and Enhanced Recovery Study

The purpose of this study is to see how well a new product called MultiStem (cell therapy) works to treat strokes. Multistem is an adult human stem cell product. The study also will investigate possible side effects from using Multistem.

Eligibility Criteria

  • Adults who have had an ischemic stroke within 36 hours of study screening

Contact Information

    Jeffrey Switzer, DP

    706 721-1691